| Detection of circulating tumor DNA in early-and late-stage human malignancies C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... Science translational medicine 6 (224), 224ra24-224ra24, 2014 | 4765 | 2014 |
| Core signaling pathways in human pancreatic cancers revealed by global genomic analyses S Jones, X Zhang, DW Parsons, JCH Lin, RJ Leary, P Angenendt, ... science 321 (5897), 1801-1806, 2008 | 4650 | 2008 |
| Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia M Kanda, H Matthaei, J Wu, SM Hong, J Yu, M Borges, RH Hruban, ... Gastroenterology 142 (4), 730-733. e9, 2012 | 834 | 2012 |
| A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas O Basturk, SM Hong, LD Wood, NV Adsay, J Albores-Saavedra, ... The American journal of surgical pathology 39 (12), 1730-1741, 2015 | 797 | 2015 |
| Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ... The American journal of pathology 179 (4), 1608-1615, 2011 | 567 | 2011 |
| Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers JD Cohen, AA Javed, C Thoburn, F Wong, J Tie, P Gibbs, CM Schmidt, ... Proceedings of the National Academy of Sciences 114 (38), 10202-10207, 2017 | 542 | 2017 |
| Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma ZA Rasheed, J Yang, Q Wang, J Kowalski, I Freed, C Murter, SM Hong, ... Journal of the National Cancer Institute 102 (5), 340-351, 2010 | 530 | 2010 |
| A combination of molecular markers and clinical features improve the classification of pancreatic cysts S Springer, Y Wang, M Dal Molin, DL Masica, Y Jiao, I Kinde, A Blackford, ... Gastroenterology 149 (6), 1501-1510, 2015 | 446 | 2015 |
| Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification SM Ahn, SJ Jang, JH Shim, D Kim, SM Hong, CO Sung, D Baek, F Haq, ... Hepatology 60 (6), 1972-1982, 2014 | 426 | 2014 |
| MicroRNA miR-155 is a biomarker of early pancreatic neoplasia N Habbe, JBM Koorstra, JT Mendell, GJ Offerhaus, JK Ryu, G Feldmann, ... Cancer biology & therapy 8 (4), 340-346, 2009 | 415 | 2009 |
| Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody H Haack, LA Johnson, CJ Fry, K Crosby, RD Polakiewicz, EB Stelow, ... The American journal of surgical pathology 33 (7), 984-991, 2009 | 405 | 2009 |
| Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels A Li, N Omura, SM Hong, A Vincent, K Walter, M Griffith, M Borges, ... Cancer research 70 (13), 5226-5237, 2010 | 339 | 2010 |
| Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria Y Zen, NV Adsay, K Bardadin, R Colombari, L Ferrell, H Haga, SM Hong, ... Modern pathology 20 (6), 701-709, 2007 | 320 | 2007 |
| MicroRNA alterations of pancreatic intraepithelial neoplasias J Yu, A Li, SM Hong, RH Hruban, M Goggins Clinical cancer research 18 (4), 981-992, 2012 | 281 | 2012 |
| Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer S Bisht, M Mizuma, G Feldmann, NA Ottenhof, SM Hong, D Pramanik, ... Molecular cancer therapeutics 9 (8), 2255-2264, 2010 | 269 | 2010 |
| Association between expression level of PD1 by tumor-infiltrating CD8+ T cells and features of hepatocellular carcinoma HD Kim, GW Song, S Park, MK Jung, MH Kim, HJ Kang, C Yoo, K Yi, ... Gastroenterology 155 (6), 1936-1950. e17, 2018 | 253 | 2018 |
| Recent updates on grading and classification of neuroendocrine tumors JY Kim, SM Hong, JY Ro Annals of diagnostic pathology 29, 11-16, 2017 | 242 | 2017 |
| Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma JK Ryu, SM Hong, CA Karikari, RH Hruban, MG Goggins, A Maitra Pancreatology 10 (1), 66-73, 2010 | 236 | 2010 |
| Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling G Feldmann, A Mishra, SM Hong, S Bisht, CJ Strock, DW Ball, M Goggins, ... Cancer research 70 (11), 4460-4469, 2010 | 226 | 2010 |
| Molecular signatures of pancreatic cancer SM Hong, JY Park, RH Hruban, M Goggins Archives of pathology & laboratory medicine 135 (6), 716-727, 2011 | 211 | 2011 |
